1312161-63-9 Usage
Description
(S)-3-N-Cbz-aminomethylmorpholine, a chemical compound with the molecular formula C15H23N3O2, is characterized by its unique structure that features a morpholine ring and a Cbz-protected amino group. (S)-3-N-Cbz-aminomethylmorpholine has garnered attention for its potential applications in the pharmaceutical and chemical industries, particularly due to its versatility as a building block in organic synthesis and its chiral nature, which is valuable in asymmetric synthesis.
Uses
Used in Pharmaceutical Synthesis:
(S)-3-N-Cbz-aminomethylmorpholine is used as a versatile building block for the synthesis of various pharmaceuticals and biologically active molecules. Its unique structure and Cbz-protected amino group make it a valuable component in the development of new drug candidates.
Used in Asymmetric Synthesis:
(S)-3-N-Cbz-aminomethylmorpholine is used as a valuable tool in asymmetric synthesis, a technique that is crucial for the production of enantiomerically pure compounds. The chiral nature of this compound allows for the creation of molecules with specific spatial arrangements, which is essential in the development of effective and selective drugs.
Used in Drug Development:
(S)-3-N-Cbz-aminomethylmorpholine is used as a potential candidate in the development of new drugs. Its pharmacological properties have been studied, and it has shown promise in various applications, making it a valuable asset in the ongoing search for novel therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 1312161-63-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,2,1,6 and 1 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1312161-63:
(9*1)+(8*3)+(7*1)+(6*2)+(5*1)+(4*6)+(3*1)+(2*6)+(1*3)=99
99 % 10 = 9
So 1312161-63-9 is a valid CAS Registry Number.
1312161-63-9Relevant articles and documents
PYRIDAZINONE DERIVATIVES AS PARP INHIBITORS
-
Page/Page column 109, (2009/06/27)
The present invention relates to compounds of formula (I): and pharmaceutically acceptable salts or tautomers thereof which are inhibitors of poly(ADP-ribose)polymerase (PARP) and thus useful for the treatment of cancer, inflammatory diseases, reperfusion injuries, ischaemic conditions, stroke, renal failure, cardiovascular diseases, vascular diseases other than cardiovascular diseases, diabetes mellitus, neurodegenerative diseases, retroviral infections, retinaldamage, skin senescence and UV-induced skin damage, and as chemo-or radiosensitizers for cancer treatment.
